Nasdaq:BFRI
#Biofrontera #Present #Micro #Main #Event WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization...
Hi, what are you looking for?
#Biofrontera #publishes #financial #results #quarter WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) — Biofrontera inc (Nasdaq: BRI) a biopharmaceutical company focused on the commercialization...
#Biofrontera #exercises #acquired #options #full WOBURN, Mass., Nov. 8, 2022 (GLOBE NEWSWIRE) — Biofrontera inc (Nasdaq: BRI) a biopharmaceutical company specializing in the marketing...
#Biofrontera #Names #Fred #Leffler #Chief #Financial WOBURN, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the...
#Biofrontera #Present #Micro #Main #Event WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization...
#BIOFRONTERA #PARTICIPATE #RENMARKS #VIRTUAL WOBURN, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (NASDAQ: BFRI), announced today that they...
#Biofrontera #Announces #Preliminary #Product #Revenues WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization...